retatrutide obesity trial results Results: 28.3% Weight Loss Data retatrutide phase 2 trial results

All products are provided on an as-is basis without warranties, express or implied

A drug with 28% mean weight loss can have very different commercial and clinical profiles depending on whether that mean is produced by a narrow cluster of super-responders or by broad consistent response across the enrolled population

A reduction in weight leads to a decrease in inflammation and improves heart health

Fujita N, Sugimoto R, Takeo M, Urawa N, Mifuji R, Tanaka H, et al

Data was self-reported by 163 surveyed customers who checked in with their provider on their second and third check-in between 4/11/22-2/5/26

Lalezarian teaches and supervises medical students, residents, and fellows as a full time teaching Professor in the Department of Radiology at UCLA